Login
$CLPT
$8.26 -$0.04 (0.48%) After hours

$CLPT SEC Filings

Filed On Filing
03 Nov 2026 SCHEDULE 13G/A
28 Oct 2026 10-Q
28 Oct 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

SOLANA BEACH, CA, October 28, 2026 – ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced financial results fo...

02 Oct 2026 Form 4: Richards Timothy T., Director

Received 319 shares as a grant or award ($3.89K)

02 Oct 2026 Form 4: Fletcher R John, Director

Received 993 shares as a grant or award ($12.1K)

03 Sep 2026 Form 4: Burnett Joseph, Director

Received 12,517 shares by exercise or conversion ($43.4K)

12 Aug 2026 SCHEDULE 13G/A
04 Aug 2026 SCHEDULE 13G/A
03 Aug 2026 10-Q
03 Aug 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

SOLANA BEACH, CA, August 3, 2026 – ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced financial results for ...

27 Jul 2026 SCHEDULE 13G/A
06 Jul 2026 Form 4: Fletcher R John, Director

Received 662 shares as a grant or award ($11.8K)

06 Jul 2026 Form 4: Richards Timothy T., Director

Received 222 shares as a grant or award ($3.96K)

02 Jul 2026 Form 4: Stigall L. Jeremy, Chief Business Officer

Received 1,781 shares as a grant or award ($21.2K)

02 Jul 2026 Form 4: D'Alessandro Danilo, Chief Financial Officer

Received 1,085 shares as a grant or award ($12.9K)

02 Jul 2026 Form 4: Burnett Joseph, Director

Received 1,361 shares as a grant or award ($16.2K)

01 Jul 2026 Form 4: Burnett Joseph, Director

Received 20,000 shares by exercise or conversion ($50K) · Sold 20,000 shares ($388K)

29 Jun 2026 144
22 Jun 2026 Form 4: Burnett Joseph, Director

Received 60,000 shares by exercise or conversion ($150K) · Sold 61,843 shares ($1.1M)

17 Jun 2026 144

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support